The aim of the present study was to determine plasma PCSK9 levels and metabolic profiles of elderly subjects with different glucose tolerance profiles (normal glucose tolerance (NGT), prediabetes (PreDM) and type 2 diabetes (T2D)) under statin therapy. This evidence concerns the gene PCSK9 and prediabetes syndrome.